Liposome-based drug and vaccine delivery system in veterinary application: Recent advancement and future trends - A review

• Published in: Annals of Animal Science
• Main Author: Sidek N.A.M.; Norpi A.S.M.; Mohamed M.; Ramli M.Z.; Nordin A.H.; Shaharulnizim N.; Mohamad M.A.; Hambali K.A.; Razik M.A.; Ismail N.; Nordin M.L.; Azemi A.K.
• Format: Review
• Language: English
• Published: Sciendo 2024
• Online Access: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85207801155&doi=10.2478%2faoas-2024-0106&partnerID=40&md5=084f860ad05c734aa8cec70845c633b3

Liposomal technology has become a significant advancement in the field of veterinary therapeutics, offering increased performance and safety in the delivery of treatments such as antibiotics, anti-inflammatories, and anti-cancer medications. With their superior stability, improved encapsulation of drugs, and more efficient transport mechanisms, nanoparticles are becoming a key tool for future uses in veterinary applications. This review article explores the latest developments and potential future applications of liposomes for delivering drugs and vaccines in veterinary medicine. Furthermore, we delve into the potential of liposomes for ground-breaking applications. These include delivering drugs precisely to specific tissues and organs, alongside the incorporation of immunomodulatory agents to boost vaccine effectiveness in veterinary medicine. It will emphasize the critical role of liposomes in the administration of vaccines and pharmaceuticals, as well as their potential as nanoscale carriers in veterinary applications. It will highlight the expanding significance of liposomes in veterinary medicine and delve into their potential as a foundational technology for advancing animal health management strategies. © 2024 Nurliyana Athirah Md Sidek et al., published by Sciendo.